Intrinsiqq
Replimune Group Inc. logo

Replimune Group Inc. Quality Score

REPL

Compare

Could not load quality data

This may be a temporary issue. If it persists, the ticker may not be covered yet.

SourceQuality score computed from the 10-Q filed 23 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 10 Nov 2026. How this is calculated.

Fiscal year ends Mar. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with REPL

CompareIntrinsic value
ARTVArtiva Biotherapeutics Inc.
$3.78-1.31%10
SRZNSurrozen, Inc.
$28.46-7.21%10
CHRSCoherus Biosciences Inc.
$0.37-4.44%10
DNAGinkgo Bioworks Holdings Inc.
$7.46-9.02%15
IMAImageneBio, Inc.
$3.92-1.51%10
EDITEditas Medicine Inc.
$1.64-4.09%40
CMPXCompass Therapeutics Inc.
$0.69+1.40%10
IBRXImmunityBio, Inc.
$6.02-8.37%30

Held by ETFs

REPL is in 26 US ETFs. The largest of them, with REPL's weight in each:

Spot a number that looks wrong? Check it in REPL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing REPL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.